At the beginning of 2021, the representatives of the Republic of Belarus inspected Farmak’s manufacturing, warehouse, laboratory facilities and the functioning of its pharmaceutical quality system. Following the inspection, the Company’s facilities engaged in manufacturing of finished medicinal products have got the EAEU GMP Certificate.
The EAEU GMP Certificate becomes a prerequisite for the registration/re-registration and sale of medicinal products in the markets of the EAEU member states (Belarus, Kazakhstan, Kyrgyzstan, etc.) and will reduce the number of inspections carried out by local regulatory authorities of the EAEU member states.
“The key thing for us is to provide consumers with high-quality innovative medicines. To achieve this, we strictly adhere to all international standards and requirements for the manufacture of medicinal products. This is clearly confirmed by the certification following world inspections which Farmak passes every year. We are now preparing for the FDA* compliance inspection to enter the U.S. market,” said Volodymyr Kostiuk, Chief Executive Officer of Farmak.
Today, Farmak’s facilities engaged in manufacturing of finished medicinal products have not only the national GMP certificate, but are also certified by the European regulatory authorities. This makes it possible to sell products in markets with particularly stringent requirements for the quality and safety of medicinal products.
Besides, last year, Dexamethasoni Phosphas with dexamethasone as an active substance was successfully prequalified by the World Health Organization and is listed among the medicinal products with proven quality and efficacy in 2 groups: HIV/AIDS and COVID-19.
At year-end 2020, Farmak increased its exports by 40%, having shipped products to more than 30 countries in the EU, Central and South America, the CIS, the Middle East, Asia, etc. Today, the share of exports in the Company’s total sales is 29.6%.
*U.S. Food and Drug Administration
Farmak took the fourth place in the sustainable development rating published by Korrespondent.net. The rating was developed and compiled by experts of Dengi.ua and Korrespondent.net in partnership with the UN Global Compact Network Ukraine. The evaluation of all rating participants was based on ESG (Environmental, Social and Corporate Governance) criteria. T...
reputation management quality In mid-May 2021, PR-Service agency presented the data on the annual rating Reputational ACTIVists. Farmak took the second place among pharmaceutical manufacturers and importers operating in Ukraine. Corporate reputation management quality rating has been compiled for more than 15 years. As the organizers say, the rating i...
Glavсom.ua has published the rating of the most expensive national brands of 2020 based on the data and calculations by MPP Consulting. It lists leading companies from various economy sectors, including Farmak as the Ukrainian pharmaceutical market leader*. MPP Consulting has been analysing the value of Ukrainian brands since 2007. According to the research ...